News
-
-
-
REGULATED PRESS RELEASE
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
-
-
-
-
REGULATED PRESS RELEASE
Successful capital increase for NFL Biosciences with over €3 million raised
NFL Biosciences successfully raises over €3 million in capital increase, securing funds for upcoming Phase 3 clinical trial of NFL-101 and advancing development of NFL-301. New shares to be listed on Euronext Growth Paris on April 16, 2024 -
-
REGULATED PRESS RELEASE
NFL Biosciences launches a fundraising round for 3 million euros through a capital increase
NFL Biosciences launches a fundraising round for 3 million euros through a capital increase, aiming to support Phase 3 clinical trial for NFL-101 and development of NFL-301 drug candidates
![Accesswire](/assets/images/accesswire-inline.png)
-
Robust Intelligence Partners With Pinecone to Secure Retrieval-Augmented Generation (RAG) AI Applications
-
Boron One Announces Successful Closing of Early Warrant Exercise Incentive Program
-
Eagle Plains Announces Conditional Approval of Warrant Expiry Extension
-
Goldflare Announces Changes in Leadership
-
Gina Corena & Associates Participates in 2024 Nevada Justice Association Annual Summer Gala This Weekend
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG resolves on investment by Volkswagen of initially 1 billion USD in Rivian Automotive, Inc., and intends to establish a joint venture
-
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
-
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
Annual General Meeting 2024 of Meyer Burger approves all motions
![Les Echos](/assets/images/les-echos.png)
-
RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
-
Schneider Electric announces the reference share price and the initial conversion/exchange ratio of its new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 and the results of the repurchase of the OCEANEs
-
FREY signs new financing for €400m
-
Schneider Electric announces the success of its offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million
-
Cie du Bois Sauvage: Buy back of own shares – week from 17/06/2024 to 21/06/2024